Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2012 /
Personalised cancer medicine and research: Today’s best practice

28th Sep - 2nd Oct 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.10.12
Views: 10803

Prof José Baselga - Massachusetts General Hospital, Boston, USA

Prof Baselga talks to ecancer at ESMO 2012 in Vienna about his future role at Memorial Sloan-Kettering Cancer Centre, it's new phase 1 programme, and the future of personalised medicine.


Focussing on non-responders to cancer therapy and learning from out liers how respond the best to new therapies.


Prof Baselga covers improved sharing of clinical trial data, assessing mutations, curiosity driven research and how next generation sequencing is set to take off in the next 2 years.


 Filming supported by Caris Life Sciences



Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation